Grupo NotreDame Intermédica

Group NotreDame Intermédica


Audit Committee

Name Office Election Year End of Mandate
José Luiz Teixeira Rossi Independent Board Member 2021 2022

Born on June 18, 1958, he graduated in Mechanical Engineering from the Federal University of Rio de Janeiro (UFRJ). Mr. José has been an independent board member of GNDI since June 2017, and since 2014 has served as CEO of Serasa Experian in Brazil and as Director of Experian in Latin America. He was also a partner at PricewaterhouseCoopers between 1989 and 2001, and between 2002 and 2008 he was responsible for IBM’s global business services in Latin America and Europe.
Mr. José served as CEO of Capgemini Brasil between January 2009 and April 2014.

Plínio Villares Musetti Independent Board Member 2021 2022

Mr. Plínio holds a bachelor’s degree in civil engineering and business administration from Mackenzie University, and has participated in a management development program at the Harvard Business School. Mr. Plínio is a partner of Janos Holding, which is responsible for equity investments. Prior to joining Janos Holding (formerly Pragma Patrimônio), he had a solid career in national and multinational companies, having been project manager and financial director of Grupo Villares between 1976 and 1992, managing director of Atlas Schindler Lifts between 1992 and 2002, partner of JP Morgan Partners between 2002 and 2007 and CEO of Satipel Industrial between 2007 and 2009. As CEO of Atlas Schindler Lifts, he led the process of operational restructuring with the entry of a private equity investor and the sale of this company , as well as participated in the integration process after the acquisition of the Atlas Elevators. As a partner at JP Morgan Partners, he was responsible for private equity investments in Latin America and active portfolio management in various industries. In recent years, he has participated in Satipel’s IPO and, as CEO of this company, has coordinated the merger with Duratex SA. Mr. Plínio is currently a member of Raia Drogasil’s Board of Directors and has served on several Board of Directors of companies such as Bresco, Adecoagro, Cacau Show, Natura, Estado de S. Paulo, Portobello, Leo Madeiras, Diagnósticos da América, Latasa, Americanas.Com, Brasil Ferrovias, Vitopel, Signatura Lazard, Eurofarma, Instituto Brazilian Corporate Governance, Sika do Brasil and the National Quality Award Foundation.

Michel David Freund Board Member 2021 2022

Born on June 18, 1969, he graduated in Business Engineering from Solvay Business School in Brussels, Belgium and holds an MBA in Business Administration from the Harvard Business School. Mr. Michel has been a board member of GNDI since February 2018, acting as a partner of Bain Capital since 2015. Between 2009 and 2014,
he served as a senior member of the CVC Capital Partners operations team, and between 2002 and 2008 served as an associate of McKinsey & Company.

Ana Paula de Assis Bógus Independent Board Member 2021 2022

Ms. Ana Paula has a degree in Business Administration from PUC / SP and also an MBA from the University of Pittsburgh. She participated in programs with the IBGC on Diversity in Councils. She has 25 years of professional experience developed mainly in multinational companies, having held several leadership positions such as BankBoston, Nestle, Walmart, Kimberly Clark in Chile. In 2017, she returned to Brazil as Head of Kimberly Clark Professional, B2B division. In 2019 she joined Rappi, initially as CEO Brazil and then as Global Head of vertical THECPG (supermarkets, pharmacies, espresso and alcoholic beverages) in the nine countries where Rappi operates.

The Audit Committee, an advisory body directly linked to the Board of Directors, shall be composed of the Chairman of the Board of Directors, two (02) members of the Board of Directors, one (01) independent member of the Board of Directors and a representative as recommended by the Company. The members of the Audit Committee shall be elected for a term of two (02) years, and re-election is permitted.

The Audit Committee shall report its activities quarterly to the Board of Directors and may meet extraordinarily as many times as it deems necessary to ensure good corporate governance.

The Audit Committee must, among other matters:

  1.  give an opinion on the hiring and dismissal of independent auditing services;
  2. review the quarterly information, interim financial statements and the financial statements;
  3. assess, monitor and recommend, to the administration, the correction or improvement of internal policies, as well as having means to receive and process information about non-compliance with applicable legal and regulatory provisions;
  4. monitor all the steps of the risk management process;
  5. monitor the progress and updating of risk mapping;
  6. monitor and ensure the application and reliability of an internal audit and internal controls;
  7. check and monitor related party transactions;
  8. identify conflicts of interest;
  9. investigate and monitor events that jeopardize internal controls or compliance of the Company; and
  10. ensure that the staff are trained and qualified to allow them to identify, anticipate, measure, monitor and, where appropriate, mitigate risks.

Charter of the Audit Committees.

Last updated on: 13/07/2021